Zacks Investment Research

Omeros (OMER) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.38 per share a year ago. These figures are adjusted...

NCS Multistage Holdings, Inc. (NCSM) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.06 per share a year ago. These figures are...

Inter Parfums (IPAR) came out with quarterly earnings of $0.26 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.26 per share a year ago. These figures are adjusted...

Ameresco (AMRC) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.23 per share a year ago. These figures are...

Tilray, Inc. (TLRY) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.29 per share a year ago. These figures are...

PTC Therapeutics (PTCT) came out with a quarterly loss of $1.15 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.46 per share a year ago. These figures are...

AllScripts Healthcare (MDRX) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.20 per share a year ago....

GreenSky (GSKY) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.11 per share a year ago. These figures are...

Everi Holdings (EVRI) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to loss of $0.04 per share a year ago. These figures...

FibroGen (FGEN) came out with a quarterly loss of $1.12 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to earnings of $0.23 per share a year ago. These figures are...

Fate Therapeutics (FATE) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to loss of $0.25 per share a year ago. These figures...

Adobe (NASDAQ:ADBE) is scheduled to report its first quarter fiscal 2020 results on Thursday, March 12. Shares of ADBE fell during last week’s coronavirus-based market correction, but this...

Dropbox (DBX) is finally looking ripe for a buy as this cloud storage giant falls to an attractive valuation. DBX debuted its shares to the public in March of 2018 and has had a rocky ride since, with...

Groupon (GRPN) has taken a nosedive since it reported Q4 earnings on February 18th. GRPN has lost 56% of its value in less than 2 weeks, and this may not be the end of misery for shareholders. This...

The week ending Feb 29 saw the U.S. market entering into the correction territory. The spike in the number of infected cases outside mainland China has made coronavirus a serious threat to global...

The markets are bouncing today following the biggest one-week drop off since the financial crisis in 2008. The Dow Jones Industrial plummeted over 3500 points last week, representing the largest...